Paula Stannard is a former deputy general counsel and acting general counsel of the U.S. Department of Health and Human Services (HHS), where she oversaw the Food and Drug, Civil Rights and Legislation divisions of the 450-attorney HHS Office of the General Counsel and provided legal advice and counsel to senior HHS officials, including the Secretary of the department, on the issues arising in their respective areas.
At Alston & Bird, Paula advises clients on regulatory questions that arise out of the on-going health care reform effort and focuses her practice on HIPAA and health information technology (including certified EHR and meaningful use issues), food and drug and other regulatory issues in the health care sector. Her HHS experience provides clients substantive knowledge of, and experience in, FDA, HIPAA, e-health and health IT, federal health insurance regulation, patient safety, and public health preparedness and emergency response issues.
Paula received her J.D. from Stanford Law School in 1990, where she was an executive editor of the Stanford Law Review, and her B.A., magna cum laude, in political science and Latin from Amherst College, where she was elected to Phi Beta Kappa. She clerked for the Honorable J.L. Edmondson of the United States Court of Appeals for the Eleventh Circuit.
- Advises health insurance companies and health plans on a variety of federal regulatory and compliance issues, including HIPAA and PPACA.
- Advises health care and other clients (including financial institutions) on regulatory requirements of, and compliance with, the HIPAA Privacy, Security, Breach Notification, and Transactions Rules, including issues relating to marketing, electronic transactions, the transition to new electronic transactions standards, and information security and breach issues.
- Advises clients on issues relating to electronic health records certification and meaningful use requirements.
-
September 6, 2011
In The Press
-
The article discusses All-Payer Claims Databases (APCD) initiatives and, specifically, how these initiatives are not uniform, with various states taking different approaches to the purpose and implantation of APCDs. This presents thorny issues for those entities that are subject to the requirements of more than one APCD. In addition, the article discusses how implementation of the APCDs presents important issues concerning ERISA.
February 7, 2012
Advisories
-
16 January 2012
Publications
-
September 6, 2011
Publications
Past Events
-
April 4, 2012
Seminar
-
March 22, 2012
Seminar
-
January 27, 2011
Seminar
-
August 31, 2010
Seminar
- American Health Lawyers Association
- Food and Drug Law Institute
- Admitted to practice before:
The Supreme Court of the United States
The Supreme Court of the State of Illinois
The Court of Appeals of the District of Columbia
The United States Court of Appeals for the Seventh Circuit
The United States District Court for the Northern District of Illinois